Abstract
Dose adjustment in obesity is particularly important for cephalosporins since these agents are widely used for surgical prophylaxis and treatment of infections. Compared with other antibiotics such as vancomycin and aminoglycosides, there is a paucity of data on the pharmacokinetics of cephalosporins in obesity and dosing recommendations are scarce. The purpose of this chapter is to review and summarise the published data to assist in developing dosing recommendations for the use of cephalosporins in obesity.
| Original language | English |
|---|---|
| Title of host publication | Drug Dosing in Obesity: Volume I: Antimicrobials |
| Editors | Syed Tabish R Zaidi, Jason A Roberts |
| Place of Publication | Switzerland |
| Pages | 27-38 |
| Edition | 1 |
| DOIs | |
| Publication status | Published - 27 Sept 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Cephalosporins'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver